Asif Rizwan
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- Medicinal Plants and Neuroprotection
Papers in
-
- S100 Proteins and Annexins 1
-
- Phytochemistry and Biological Activities 2
- Plant-Microbe Interactions and Immunity 2
- Co-authors
- Riffat Yasmin (4 shared papers)Muhammad Farhan Asif (1 shared paper)Xiaohui Ni (2 shared papers)Inna Serganova (2 shared papers)Ronald G. Blasberg (2 shared papers)Sunitha B. Thakur (2 shared papers)Jason A. Koutcher (3 shared papers)James Russell (1 shared paper)
- Journals
- Dose-Response (4 papers)Clinical Cancer Research (2 papers)Bioinformatics and Biology Insights (1 paper)NMR in Biomedicine (1 paper)Infectious Disorders - Drug Targets (1 paper)
- Partner nations
- PakistanUnited StatesThailand
In The Last Decade
Asif Rizwan
17 papers receiving 526 citations
Peers
Comparison fields: 5 of 88
- Cancer Research 133
- Complementary and alternative medicine 33
- Pharmacology 26
- Materials Chemistry 123
- Molecular Biology 144
Countries citing papers authored by Asif Rizwan
This map shows the geographic impact of Asif Rizwan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asif Rizwan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asif Rizwan more than expected).
Fields of papers citing papers by Asif Rizwan
This network shows the impact of papers produced by Asif Rizwan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asif Rizwan. The network helps show where Asif Rizwan may publish in the future.
Co-authors
The 25 scholars most cited alongside Asif Rizwan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 154 | |
| 2 | 2013 | 92 | |
| 3 | 2011 | 91 | |
| 4 | 2021 | 37 | |
| 5 | 2021 | 30 | |
| 6 | In vivo antiviral potential of Glycyrrhiza glabra extract against Newcastle disease virus. | 2017 | 29 |
| 7 | 2021 | 24 | |
| 8 | 2021 | 20 | |
| 9 | 2022 | 18 | |
| 10 | 2022 | 17 | |
| 11 | 2022 | 6 | |
| 12 | 2020 | 5 | |
| 13 | 2023 | 4 | |
| 14 | 2011 | 3 | |
| 15 | 2023 | 3 | |
| 16 | 2023 | 2 | |
| 17 | 2021 | 1 | |
| 18 | 2023 | 0 |
About Asif Rizwan
Asif Rizwan is a scholar working on Molecular Biology, Plant Science, Pulmonary and Respiratory Medicine, Oncology and Cell Biology, having authored 18 papers that have together received 536 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (3 papers), Plant Pathogens and Fungal Diseases (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Phytochemistry and Biological Activities (2 papers), Plant-Microbe Interactions and Immunity (2 papers), Pharmacological Effects of Natural Compounds (2 papers), S100 Proteins and Annexins (1 paper) and Nanoparticles: synthesis and applications (1 paper). The work is most often cited by research in Cancer Research (133 citations), Complementary and alternative medicine (33 citations), Pharmacology (26 citations), Materials Chemistry (123 citations) and Molecular Biology (144 citations). Asif Rizwan has collaborated with scholars based in Pakistan, United States and Thailand. Frequent co-authors include Riffat Yasmin, Muhammad Farhan Asif, Xiaohui Ni, Inna Serganova, Ronald G. Blasberg, Sunitha B. Thakur, Jason A. Koutcher, James Russell, Jelena Vider and Mukhtiar Ahmad. Their work appears in journals such as Dose-Response, Clinical Cancer Research, Bioinformatics and Biology Insights, NMR in Biomedicine and Infectious Disorders - Drug Targets.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.